Prostate cancer: Diabetes and prostate cancer--an open debate.

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

Who cites it

8 citing papers in PubMed.

1. Association between body mass index and hemoglobin A1c with serum prostate-specific antigen level: A retrospective cohort study.Saudi medical journal · 2023
   Article
2. The Association of Nighttime Fasting Duration and Prostate Cancer Risk: Results from the Multicase-Control (MCC) Study in Spain.Nutrients · 2021
   Article
3. Is Type 2 Diabetes Causally Associated With Cancer Risk? Evidence From a Two-Sample Mendelian Randomization Study.Diabetes · 2020
   Article
4. Moderating effects of sleep duration on diabetes risk among cancer survivors: analysis of the National Health Interview Survey in the USA.Cancer management and research · 2018
   Article
5. Insights into the relationships between diabetes, prediabetes, and cancer.Endocrine · 2017
   Review
6. Incidence and Mortality Risks of Cancer in Patients with Type 2 Diabetes: A Retrospective Study in Shanghai, China.International journal of environmental research and public health · 2016
   Article
7. Metabolic syndrome and prostate cancer risk in a population-based case-control study in Montreal, Canada.BMC public health · 2015
   Article
8. New insights into pancreatic cancer-induced paraneoplastic diabetes.Nature reviews. Gastroenterology & hepatology · 2013
   Review

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

Authors and funding

2 authors.

Funding

No grant is acknowledged in the PubMed record.

Abstract

PubMed holds no abstract for this paper.

Indexed as